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TCT-553
The Impact of Periprocedural Myocardial Infarction on Long-Term Outcomes
After Carotid Artery Stenting
Christopher Metzger1, Robert Hibbard2, Douglas Massop3, Rasesh Shah4, Tift
Mann5, Majdi Ashchi6
1Holston Valley Medical Center, Kingsport, TN; 2Bryan Heart Institute, Lincoln, NE;
3Iowa Clinic, Des Moines, IA; 4Sentara Norfolk, Norfolk, VA; 5Wake Hospital, Wake
Forrest, NC; 6Memorial Medical Center, Jacksonville, FL
Background: Previous studies comparing carotid artery stenting to carotid
endarterectomy have shown an increased risk of periprocedural myocardial (MI)
associated with endarterectomy. While findings from the CREST trial revealed that
periprocedural MI has a lesser effect on health status at 1-year compared with stroke,
other studies have demonstrated a strong correlation between periprocedural MI and
long-term mortality. The impact of periprocedural MI after carotid artery stenting on
both 30-day and 1-year mortality has never been clearly indentified.
Methods: SAPPHIRE Worldwide is a prospective, multicenter, observational study to
evaluate the risk of major adverse events (MI, death and stroke) after carotid stenting
by investigators with varied levels of experience and utilizing a formal training
program.
Results: To date, over 10,000 patients have been enrolled and completed 30 day follow
up. More than 7,600 of these patients have completed 1-year follow up evaluation.
Thirty percent of those enrolled were symptomatic and 46% were age 75 years or older.
Periprocedural MI occurred in 0.6% patients (9 Q-wave, 54 Non-Q wave), and one
additional Q-wave MI occurred between 30 days and 1 year. Of patients who
experienced an MI, 22% resulted in periprocedural death and 36% resulted in death at
1-year follow up.
Conclusion: The incidence of periprocedural MI, although less frequently seen after
stenting than endarterectomy, can result in a high rate of mortality in both in the short
and long term. Identification of patients at high risk for periprocedural cardiovascular
events is an important consideration prior to carotid revascularization.
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TCT-554
The iliac side branch: for all or only the few? - a morphological suitability study
Daphne Pavlidis, Christian Jakobs, Jan Brunkwall, Michael Gawenda
Vascular and Endovascular Surgery, University Hospital Cologne, Cologne,
Germany
Background: Endovascular aneurysm repair for aneurysms extending to the iliac
artery is still a challenge. Interventional occlusion of the hypogastric artery and thus
creating a distal landing zone in the external iliac artery is a common method with
method specific morbidity (buttock claudication, impotence). As alternative iliac side
branched stentgrafts can maintain pelvic blood supply, but the morphological
applicability is limited. Aim of the study was to investigate the morphological
applicability of commercially available iliac side branches (COOK Zenith branched
graft - ZBIS) in our patients’ population with aortoiliac aneurysms.
Methods: A retrospective single-centre study was conducted of 50 patients (45 men;
median age 71.5 years, range 53-90) undergoing repair of aortoiliac aneurysms (open
repair, hypogastric occlusion prior to EVAR and ZBIS) between 2008 and 2010. All
available CT angiograms with post-processing imaging were compared to criteria for
morphological applicability to the (1) manufacturer’s instruction for use (IFU) and to
(2) criteria published by experienced surgeons in the literature as well as to the (3) in-
house institutional protocol of our department.
Results: In 50 patients, 69 targeted iliac aneurysms were studied. Of these, 29/69
(42%) were compliant to the manufacturer’s IFU (1), 25/69 (36%) were compliant to
the published criteria (2), 38/69 (55%) were compliant to the in-house protocol (3).
Most common morphological exclusion criteria were an aneurysmatic hypogastric
artery.
Conclusion: Stent-grafts with an IIA side branch offer an opportunity to repair
aortoiliac aneurysms without sacrificing the hypogastric artery, but not all aneurysms
are morphological suitable. In our patients’ population with aortoiliac aneurysm,
maximum 55% could have been treated with an iliac side branch based on the current
experience. Especially aneurysmatic hypogastric artery and extreme tortuosities of the
iliac arteries seem to be a limiting factor for the use of iliac side branches.
TCT-555
Higher CD34+ Cells Concentration and Lower Degree of Inflammation are
Associated with Better Therapeutic Response to Autologous Bone Marrow Cells
Application in Patients with Critical Limb Ischemia
Juraj Madaric1, 2, Andrej Klepanec1, 2, Marek Toth2, Martin Mistrik3, Martina
Valachovicova1, Ingrid Olejarova2, Roman Necpal2, Rastislav Bazik2, Zoroslav Zita2,
Branislav Liska2, Augustin Mistrik1, 2, Ivan Vulev1, 2
1Slovak Medical University, Bratislava, Slovakia; 2National Cardiovascular
Institute, Bratislava, Slovakia; 3Clinic of Haematology and Transfusiology, Faculty
Hospital, Bratislava, Slovakia
Background: The aim of our study was to analyzed factors associated with the
therapeutic benefit of autologous bone marrow cells (BMC) application in patients
(pts) with critical limb ischemia (CLI).
Methods: Forty-one patients (age 66±10 years, M:F 35:6) with advanced CLI
(Rutherford category 5,6) not eligible for revascularization were randomized to
treatment with 40ml of BMC either using local IM (n=21) or selective IA infusion
(n=20). Primary end points were limb salvage and wound healing. Secondary end
points included changes in transcutaneous oxygen pressure, quality of life questionnaire
(EQ 5D), ankle-brachial index, and pain scale (0-10 scale). Patients with limb salvage
and wound healing were considered as responders to BMC therapy.
Results: At 6-months follow-up, in the entire cohort the limb salvage was 73% (27/37),
four pts died unrelated to stem cells therapy. At univariate analysis, the CD34+ cells
count >20x10^6 was associated with a positive therapeutic response to BMC therapy
(p=0.015, OR 4.7 (95% CI 1.15-19.24)), and peripheral blood leukocytes count
>10x10^9/l was associated with negative therapeutic response (p=0.006, OR 2.1 (95%
CI 1.06-4.1)), as well as CRP level >10mg/l (p=0.038, OR 1.54 (95% CI 1.01-2.32)).
By multivariate analysis the number of administrated CD34+ cells >20x10^6 emerged
as an independent predictor of clinical benefit after BMC application (p=0.03) with
80% specificity and 65% sensitivity. Importantly, there were no differences in IM
versus IA application after 6 months in all observed parameters.
Conclusion: Higher CD34+ cells concentration, and lower degree of inflammation are
associated with better clinical therapeutic response to BMC therapy in pts with CLI.
Both IM and IA cells delivery are effective and comparable therapeutic strategies.
TCT-556
Percutaneous Transluminal Angioplasty of the Subclavian Arteries. Long-term
Follow up
Michel Henry1, 2, Isabelle Henry3, Antonios Polydorou4
1CABINET DE CARDIOLOGIE, Nancy, France; 2Global Reseach Institute,
Hyderabad, India; 3Polyclinique Bois Bernard, Bois Bernard, France; 4Pantaleimon
General Hospital, Athens, Greece
Background: To review feasibility, safety and long-term results of subclavian artery
angioplasty.
Methods: 357 pts (˛:205, mean age:65.2±12 y) underwent percutaneous treatment
for subclavian artery(SA) occlusive disease (stenosis:254, occlusion:92).Left:272,
Right:85, Innominate Artery:18. Etiology: atheromatous:349,others:8 (Takayasu:4)
Mean% stenosis 82.8 ±7.7. Mean lesion length:23.7 ± 8.9mm Indications for treatment
were upper limb ischemia (ULI) (n=167) Vertebrobasilar insufficiency (VBI)
(n=137),associated VBI and ULI (n=103), coronary steal syndrome (n=16)
asymptomatic pts with severe coronary disease (n=53) 29 pts had associated Vertebral
Artery stenosis,71 carotid stenoses,303 lesions were prevertebral,35 post vertebral,
both 19. Percutaneous techniques included retrograde femoral (n=257), brachial artery
(n=71) access or both (n=29) and in 6 cases the “pull through technique”). An isolated
balloon angioplasty was performed in 59 cases and 298 stents were implanted (balloon
expandable:236, self expandable:62.
Results: Technical success was obtained in 339 lesions (95 %) 100% for stenoses.
Only 74 occlusions were recanalized (80 %). Four periprocedural events occurred (1.2
%),1 major (fatal stroke),1 TIA, 2 arterial thromboses. At follow-up (mean follow-
up:68.7 months±37.5),we had 37 restenoses (12 %).13 occurred following angioplasty
alone(18.8 %) and 24 following angioplasty and stent implantation (8.6 %)
(P<0.01).Primary (PI) and secondary (PII) patencies on an intention to treat basis at
10-y follow-up were 79.5% and 85.7% respectively. In pts without initial stent
placement, the rates were 67.5% and 75.5% while in those with stents, the rates rose
to 91.2% and 97.6% (P<0.01).PI for all recanalized lesions were 85.3%, 79.1% without
stent,91.2% with stent (P<0.04) and PII 92.3%,88.5%,97.6% respectively (P<0.02).
Conclusion: P.T.A. is currently the treatment of choice for subclavian artery lesions.
It is a safe and effective procedure associated with low risks and good long-term results.
Stents seem to limit the restenosis rate and improve long-term results
TCT-557
Thoracic abdominal endovascular aneurysm repair (TEVAR) in the
management of Acute Aortic Syndrome (AAS). An early experience with de-
branching, chimney techniques and Multi-Layer stenting
Sherif Sultan1, 2, Peadar Waters1, Niamh Hynes2, 1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Background: 33 TEVAR were performed for 31 patients (13 females: 18 Males) over
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a period of 36 months of which six were emergencies. The mean age was 64.6 years.
26 patients were ASA Grade III or more.
Methods: Risk factors were hypertension (n=20), hypercholesterolaemia (n= 17),
smoking (n=14) and ischaemic heart disease (n=9). 17 procedures were for thoracic
abdominal aneurysms type three, 7 thoraco-abdominal aneurysms type four, 4 aortic
dissection Type B, 1 infantile adult aortic coarctation and 2 spontaneous supra visceral
aortic ruptures. Seven patients underwent a one/ two stage hybrid debranching of
visceral vessels followed by TEVAR. Fourteen patients underwent chimney or Snorkel
Endografting of Subclavian or renal vessels. Two patients underwent multilayered
stenting for thoraco-abdominal aneurysms with visceral involvement. One patient had
a CPS stent for infantile adult coarctation.
Results: Primary endpoints were 6% mortalities within 30 days for the two acute
emergencies of which one was a HIV patient with syphilitic aneurysm. 30 day
morbidity was one acute tubular necrosis and one lower respiratory tract infection.
Aneurysm free survival time was 19months. No patients developed aneurysm rupture,
paraplegia or stroke. Four cases of endoleak were witnessed however no aneurysm
expansion was experienced. Two patients required re-intervention for graft migration.
Conclusion: We display from our experience that minimal invasive techniques with
TEVAR and debranching, chimney, snorkel and multilayered stent grafting of visceral
vessels is safe, prudent and economically viable. The development of multilayered
stenting technique looks ever promising for future management of complex aortic
pathologies.
TCT-558
5-year THUNDER Follow-Up: Patients with PAD Treated with Uncoated
Versus Paccocath Paclitaxel Coated Balloons
Gunnar Tepe
RoMed Klinikum Rosenheim, Rosenheim, Germany
Background: Restenosis remains the primary limitation following femoropopliteal
PTA, with rates of 40 - 60% at 1 year. Multiple prospective, randomized studies
(FemPac, THUNDER) evaluated the concept of localized antiproliferative drug
delivery for the prevention of restenosis in the peripheral arteries using Paccocath®
paclitaxel coated balloons versus uncoated balloons. These studies demonstrated
favorable results for the Paccocath balloon cohort on late lumen loss (LLL) and target
lesion revascularization (TLR) rates up to 2 years post index procedure. The purpose
of this study is to assess long term efficacy results of the Paccocath balloon versus an
uncoated balloon.
Methods: Patients who were originally enrolled and treated in the THUDNER trial
were re-consented to enable the 5-year follow-up data collection. The clinical data
(e.g., TLR, deaths, amputations, bypass surgery, etc.) and angiograms were collected
up to 5 years follow-up. The 5-year clinical and angiographic data analyzed by an
independent angiographic core laboratory were compared to the previously reported
baseline, 6, 12, and 24 months data to assess the long-term effect of the Paccocath
balloon.
Results: The data is currently being monitored. However, the preliminary analysis
demonstrated that TLR rates are significantly lower in the Paccocath balloon group
compared to the uncoated balloon group. As confirmed by 5-year follow-up visits,
approximately 70% of patients in the Paccocath balloon group did not require any
additional target lesion treatment (e.g., TLR) from the time of the index procedure
compared to approximately 30% of patients in the uncoated balloon group. In addition,
the time to the first TLR from the index procedure is significantly longer in the
Paccocath balloon group compared to the uncoated balloon group. Besides clinical and
angiographic data, the finding that severe dissections left with no stent implantation in
the Paccocath group was a predictor of favorable long term outcomes will be presented
at TCT 2011.
Conclusion: The Paccocath balloon demonstrated superior long-term results compared
to the uncoated balloon when used for the treatment of femoropopliteal arteries.
TCT-559
Impact of Angiosome Approach on Clinical Outcomes of Endovascular Therapy
in Patients with Critical Limb Ischemia Presenting with Isolated Below-the-
Knee Lesions
Kiyonori Nanto1, Osamu Iida1, Shin Okamoto1, Tomoharu Dohi1, Yoshimitsu Soga2,
Keisuke Hirano3, Daizo Kawasaki4, Kenji Suzuki5, Yusuke Miyashita6, Hiroto
Terashi7, Shinsuke Nanto8, Masaaki Uematsu1
1Kansai Rosai Hospital, Amagasaki, Japan; 2Kokura Memorial Hospital,
Kitakyushu, Japan; 3Saiseikai Yokohama-city Eastern Hospital, Yokohama, Japan;
4Hyogo College of Medicine, Nishinomiya, Japan; 5Sendai Kosei Hospital, Sendai,
Japan; 6Shinshu University School of Medicine, Matsumoto, Japan; 7Kobe
University Graduate school of Medicine, Kobe, Japan; 8Osaka University Graduate
school of Medicine, Department of Advanced Cardiovascular Theraputics, Oosaka,
Japan
Background: We investigated whether the angiosome concept is useful in
endovascular therapy (EVT) of critical limb ischemia (CLI) patients with isolated
below-the-knee (BTK) lesions and assessed factors influencing major amputation (MA)
in direct and indirect groups.
Methods: We analyzed 369 limbs from 329 consecutive patients (male=224, age;
70±11 years) with ischemic ulceration/gangrene, presenting with isolated BTK lesions
(Rutherford 5: 270 limbs and 6: 99 limbs, respectively). We classified these patients
into direct (n=200) and indirect (n=169) groups depending on whether feeding artery
flow to the site of ulceration/gangrene was either successfully achieved or not based
on the angiosome concept. Rates of amputation-free survival (AFS), freedom from
major amputation (MA) and from major adverse limb events (MALE) were compared
between direct and indirect groups by Kaplan-Meier analysis and log-lank test.
Multivariate analysis was performed to explore the independent determinants of limb
salvage in the direct and indirect groups.
Results: During follow-up (mean 18±16months), the overall limb salvage rate was
81% (300/369), and death occurred in 36 % (119/329) of patients. Rates of AFS (39±7
vs. 30±7, p=.04), and freedom from MA (79±4 vs. 72±4, p=.05) and from MALE (46±6
vs. 29±8, p=.02) were significantly higher in the direct group than in the indirect group
for up to 4 years after index procedure. After multivariate Cox proportional analysis,
HbA1c (hazard ratio [HR], 1.4; 95% confidential interval [CI]: 1.1-1.9; P=0.007) and
administration of cilostazol (HR, 0.27; 95% CI, 0.11-0.68 1.1; P=0.0055) in the direct
group and C-reactive protein level (HR, 1.4; 95% CI, 1.1-1.7; P=0.001) in the indirect
group were the independent factors associated with MA by multivariate analysis.
Conclusion: Achieving direct flow by EVT based on the angiosome concept in CLI
patients with isolated BTK lesions is important for AFS, FFMA and FFMALE. Limb
salvage factors appear to differ between patients with and without direct flow from the
feeding artery after EVT.
TCT-560
Results of the CONFIRM II Study Demonstrate the Value of Orbital
Technology in Effectively Restoring Flow in Patients with Calcified Infra-
Inguinal Disease
Gaurav Aggarwala1, J. Miles McClure2, Dinesh Arab3, David Prewitt5, Sumeet
Sachdev4
1Utah Cardiology, Layton, UT; 2MidMichigan Heart & Vascular Center, Saginaw,
MI; 3Florida Hospital Memorial Medical Center, Daytona Beach, FL; 4Saint Alexus
Medical Center, Hoffman Estates, IL; 5Legacy Heart, Plano, TX
Background: While guidelines for the diagnosis and management of patients with
peripheral arterial disease (PAD) are well established, appropriate use of recently
introduced endovascular therapies is less defined. Clinical data from a real-world
patient population is needed to determine device utility and procedure success. The
CONFIRM Series was designed to validate the efficacy of orbital treatment in patients
with obstructive infra-inguinal disease.
Methods: The CONFIRM II Study is a prospective registry of 1,127 consecutive
patients with 1,712 infrainguinal and infrapopliteal lesions treated with the latest orbital
crown technology, Predator 360 (Cardiovascular Systems, Inc., St. Paul, MN). It
follows the CONFIRM I Study that evaluated the effectiveness of earlier device
iterations. Descriptive acute procedural data was collected by 153 investigators at 122
institutions.
Results: Patients were 70.7 years; 61.5% male. Comorbidities were renal disease
(35.4%), current or previous smokers (69.8%), diabetes (57.8%), CAD (73.2%), HTN
(91.2%), and hyperlipidemia (79.2%). Lesion morphology: mild to severe calcium
(90%). Lesion location: superficial femoral and other proximal vessels (52%), popliteal
(17%), and tibials (31%). Average lesion length: 72 mm. Device run time averaged
103 seconds per patient, followed by angioplasty (mean 5.44 atms) in 86% of lesions.
Bail-out stenting due to dissection: 2.5% of lesions. Average stenosis: 87.8% pre-
procedure, 33.9% post orbital and 9.6% post adjunctive. Procedural events included
minor and major dissection (7.8%), perforation (0.4%), slow flow (3.8%), abrupt
closure (1.4%) and distal macro embolization (1.9%).
Conclusion: The CONFIRM II Study validates the use of the latest iteration of orbital
technology in restoring flow by changing lesion compliance, thus allowing low-
pressure balloon angioplasty with limited complications and reduced need for bailout
stenting. This data contributes to a large and growing database showing predictable,
repeatable results of orbital technology in small, calcified vessels.
TCT-561
New Conformable Thoracic Stentgraft (SG) – Apposition Scoring in the
Thoracic Aorta Near the Arch
Michael Gawenda, Sabrina Nothdurft, Mareike Hörmann, Jan Brunkwall
Department of Vascular Surgery, University of Cologne, Cologne, Germany
Background: Current thoracic SG complies poorly with the curvature of the aortic
arch. Two new conformable SG were introduced to the European market. Due to the
different designs it is postulated, that the new SG are allowed for better apposition to
the aortic wall. We now report the first clinical experience with this technique in 45
patients.
Methods: Since 6/2009, 45 pts (33 m; 67.5(45-85)yrs) were treated for descending
thoracic aorta pathologies near the arch (TAA:27, acute dissection:9, chronic
dissection:7, trauma:2) with new thoracic SG (Zenith® TX2™Pro-Form™,n=10;
Conformable GORE TAG®,n=35). Additional arch debranching was performed in 17
cases. Evaluating the post-operative CT imaging apposition of the SG to the aortic wall
was scored (1 point (excellent): circular, 2 points (good): >2/3 circumferential, gap to
inner curve <1cm; 3 points (bad): <2/3 circumferential, gap inner curve >1cm; 4 points:
type Ia endoleak).
Results: The modified thoracic SG were correctly deployed in 42/45 pts. In one patient,
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